M&A Deal Summary |
|
|---|---|
| Date | 2021-10-01 |
| Target | TRY |
| Sector | Marketing |
| Buyer(s) | Ferd Capital |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
Ferd Capital is the direct investment arm of Norwegian holding company and asset manager Ferd AS. Ferd Capital looks to make 500 million NOK to 3 billion NOK equity and debt investments in private and public companies. The Firm does not have any sector preferences and generally pursues opportunities throughout Scandianavia. Ferd looks to take an active ownership role to help with portfolio company growth and development. Ferd Capital is based in Oslo, Norway.
| DEAL STATS | # |
|---|---|
| Overall | 10 of 13 |
| Sector: Marketing M&A | 1 of 1 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 4 of 4 |
| Country: Norway M&A | 10 of 11 |
| Year: 2021 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-03-18 |
Norkart
Oslo, Norway Norkart provides in-house developed software and data platform for map solutions to the public and private sectors. Norkart was founded in 1961 and is based in Sandvika, Norway. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-02-22 |
Aidian
Espoo, Finland Aidian develops, manufactures, and sells instruments and tests that are used in such fields as primary care to provide quick and accurate test results. The company's offering of tests addresses several global health problems such as antimicrobial resistance (AMR), diabetes, and colorectal cancer. It has tests that are intended to reduce unnecessary prescriptions of antibiotics, which is a driver behind the growing threat from AMR and antibiotic-resistant bacteria. Aidian was founded in 1974 and is based in Espoo, Finland. |
Buy | - |
